VDyne
PrivateLast Round
VC Round
Oct 24, 2022
Total Funding Raised
$21M
Company Overview
VDyne is a medical device company developing a minimally invasive transcatheter valve replacement system to treat tricuspid regurgitation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VDyne Comparables
Compare VDyne with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Laplace Interventional | 93% | |
| T-Heart | 93% | |
| Trisol Medical | 92% | |
VDyne Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 24, 2022 | ||||
| Series C | Jan 6, 2021 |
VDyne Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jean Boulle Medtech | VC Round, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 6, 2025
Monthly visitors increased 42% MoM.
- May 6, 2025
Grew 16% QoQ from 25 to 29 employees.
VDyne Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VDyne's valuation, stock price, and market status.